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Abstract 
  
 Phagocytosis is the central process by which macrophage cells internalize and eliminate 
infectious microbes as well as apoptotic cells. During maturation, phagosomes containing engulfed 
particles fuse with various endosomal compartments through the action of regulatory molecules on the 
phagosomal membrane. In this study, we performed a proteomic analysis of the membrane fraction from 
latex bead-containing (LBC) phagosomes isolated from macrophages. The profile, which comprised 546 
proteins, suggests diverse functions of the phagosome and potential connections to secretory processes, 
toll-like receptor signaling and autophagy. Many identified proteins were not previously known to reside in 
the phagosome. We characterized several proteins in LBC phagosomes that change in abundance upon 
induction of autophagy, a process that has been previously implicated in the host defense against 
microbial pathogens. These observations suggest crosstalk between autophagy and phagocytosis that 
may be relevant to the innate immune response of macrophages.              
 
Introduction 
 
 Phagosomes are specialized membrane-bound organelles generated in phagocytic cells such as 
macrophages, neutrophils and dendritic cells. Their purpose is to internalize foreign particles, 
microorganisms or apoptotic cells in order to mount an immune response or maintain tissue homeostasis 
(1). The nascent phagosome undergoes a complex maturation process involving sequential fusion with 
endosomal compartments. Once mature, the phagosome degrades its constituents and facilitates antigen 
presentation in a highly controlled manner (2-4). Insight into the biogenesis and immunity-related 
functions of the phagosome has come from analysis of its protein contents. Previous studies have profiled 
the proteomes of latex bead-containing (LBC) phagosomes in cell lines from mice (5-7) and Drosophila 
(8), as well as Dictyostelium discoideum (9) and Entamoeba histolytica (10). These elegant studies have 
contributed to our understanding of phagosome maturation (6, 9) and modulation by cytokines (7). 
However, because the entire contents of the phagosomes were sampled, abundant proteins such as 
soluble lysosomal hydrolases might have obscured lower abundance membrane-bound regulatory 
proteins or signaling factors.  
 In order to identify such lower abundance species, we enriched integral and peripheral membrane 
proteins from macrophage LBC phagosomes by organelle sub-fractionation before carrying out a large-
scale proteomic analysis. The 546 proteins identified in our study included 49 membrane receptors, 64 
transporter proteins, 107 regulators of vesicle and protein trafficking (including GTPases), and many 
components from cellular machineries other than phagosomes. One of the new proteins exclusively found 
in our study, LC3-II, is considered a marker of autophagy activity. Its presence in phagosomes suggests 
an unexplored linkage between autophagy and phagocytosis. Apart from its housekeeping role in 
maintaining cellular homeostasis, autophagy has been implicated in cancer, neurodegerative disorders, 
aging and more recently, immunity against intracellular microbes (11-13).  We show here that LC3-II 
levels in phagosomes are modulated by autophagic activity, along with several other proteins not 
previously associated with autophagy. These results underscore the power of membrane-specific 
phagosomal proteomics for identifying new processes that this organelle may engage in. 
Experimental Procedures 
  Antibodies - The rat anti-LAMP1 mAb, mouse anti-GM130 mAb, mouse anti-calnexin mAb, 
mouse anti-HSP 60 mAb and mouse anti-JAK1 were from BD Biosciences. The goat anti-EEA1 pAb, 
rabbit anti-vacuolar ATPase pAb, and goat anti-cathepsin D pAb were from Santa Cruz Biotechnology.  
The rabbit anti-VAMP4 pAb and rabbit anti-actin pAb were from Abcam. The rabbit anti-LC3B pAb and 
mouse anti-tubulin mAb were from Sigma. The mouse anti-Transferrin receptor mAb was from Zymed 
Laboratories. The rabbit anti-TLR7 pAb was from Cell Signaling. The rat anti-HA mAb (clone 3F10) was 
from Roche Applied Science. All secondary Abs for Western blots were from SouthernBiotech.  
 Phagosome Isolation and Membrane Fractionation – The murine macrophage cell line 
J774A.1 was cultured as a monolayer in DMEM medium supplemented with 10% fetal bovine serum, 100 
units/mL penicillin/streptomycin, and 2 mM L-glutamine (GIBCO). Another macrophage cell line, RAW 
264.7 stably expressing HA tagged-TLR9, was cultured in RPMI-1640 (GIBCO, formulated with HEPES 
and glutamine) supplemented with 10% fetal bovine serum and 100 units/mL penicillin/streptomycin. Both 
cell lines were incubated with 0.8 µm blue-dyed latex beads (Sigma) for 1 h at a multiplicity of infection at 
50:1 to generate phagosomes, washed with ice-cold PBS and incubated in new medium for 1 h. Each cell 
internalized 5-10 microbeads. After gentle cell lysis using a Dounce homogenizer to reach 90-95% 
breakage, the bead-containing phagosomes were isolated on a sucrose gradient described by Desjardins 
and coworkers (14) . The phagosome band on top of the sucrose gradient (10%) as well as three 
additional bands (fractions 1, 2, 3) at the gradient interfaces beneath (25%, 35% and 60%) were collected 
[Supporting information (SI) Fig. S1). Fractions 1, 2 and 3 were subjected to TCA-mediated protein 
precipitation followed by acetone wash, then centrifuged to acquire protein pellets. The pellets were 
dissolved in 4% SDS in 50mM Tris-HCl buffer (pH 8.0) by vortexing on an agitator (Eppendorf) at 1400 
rpm for 1 h at 20 °C.   Protein solutions obtained from the supernatant after centrifugation (14000 rpm X 
15 min at 4 °C) were used for immunoblots. 
The phagosome fraction was resuspended in PBS containing protease inhibitor cocktail 
(Calbiochem) and washed by ultracentrifugation. The pelleted phagosomes were either resuspended in 
4% SDS buffer for total protein extraction as described above or subjected to further fractionation for 
enriching membrane-bound proteins using the following protocol. Washed phagosomes were 
resuspended in 0.2 M Na2CO3 (pH 11.0) and the organelle membranes were disrupted by 5-7 passages 
of the suspension through a 25G syringe needle. The resulting sample was left on ice for 30 min before 
the membrane fraction was pelleted by centrifugation for 45 min at 200,600 x g at 4 °C. Luminal soluble 
proteins from the supernatant were precipitated and redissolved similarly to the proteins in fraction B1-B3 
in order to obtain a concentrated protein mixture. The phagosomal membrane pellet was directly 
resuspended in 4% SDS buffer for protein extraction as described above. All the protein extracts were 
diluted two-fold with 50 mM Tris-HCl buffer before the protein concentration was determined by the BCA 
assay (Piece). 
 SDS-PAGE and In-gel Digestion - In order to profile membrane-bound components of 
macrophage phagosomes, 35 µg of membrane-extracted proteins were separated by SDS-PAGE (4-12%, 
Bio-Rad).  The entire Coomassie-stained gel was cut into 23 consecutive bands and the gel slices were 
subjected to in-gel digestion via a standard procedure described by Gu et al. (15)  Notably, the 
phagosome isolation, membrane fractionation, protein separation and digestion were repeated to acquire 
duplicate proteome samples for analysis using two types of mass spectrometers as described below. 
              Protein Identification by LC-MS/MS and Data Analysis - The in-gel digest of each band was 
further separated by liquid chromatography and analyzed by electrospray ionization tandem MS. In brief, 
all the peptide digests were first dried on a speed vacuum and reconstituted in 20 µl of 0.1% formic acid 
(FA). Each sample was injected onto a LC Packings PepMap100 trapping column (0.3 mm × 5 mm). 
Reversed-phase separation was completed on a LC Packings PepMap C18 column (3 μm, 0.075 × 150 
mm) at a flow rate of 200 nl/min using buffers 2% CH3CN, 0.1% FA (A) and 80% CH3CN, 0.1% FA (B).  
The gradient was 0-30% B in 100 min, 30-100% B in 10 min, and 100% B for 10 min.  The eluted 
peptides were injected into a given type of nanoESI-MS/MS instrument for protein identification. 
To maximize the membrane proteome recovery, we prepared biological replicates to be analyzed 
by either ESI Q-TOF Mass Analyzer (QSTAR® Hybrid Quadrupole TOF, Applied Biosystems) or ESI 
Linear Ion Trap Mass Analyzer (LTQ, Thermo Inc.) in a data-dependent acquisition mode. The QSTAR 
system carried out a survey scan in the mass range of m/z 350-1600. Up to three precursor ions 
exceeding the peak intensity of 30 ion counts were selected automatedly for fragmentation in MS/MS 
analysis. Product ions were detected in the range of m/z 70-2000. The instrument was calibrated and 
tuned following each batch of six injections.  The major parameters for LTQ data acquisition were: scan 
range, 400-2000 m/z; precursor ion selection, 6 most abundant peaks per scan for MS/MS; minimal ion 
signal, 500; and normalized collision energy, 35.0 %. 
  LC-MS/MS data collected from both instruments were analyzed using the Mascot (version 
2.1.03, Matrix Science, UK) search engine on a non-redundant International Protein Index (IPI) mouse 
database (version 3.24 >50,000 entries). Up to one missed trypsin cleavage was allowed, and 
carboxyaminomethylation and Met oxidation were selected as a fixed and variable modification, 
respectively. The mass tolerance for an individual set of data is: for QSTAR data, parent mass error 0.1 
Da, fragment mass error 0.15 Da; for LTQ data, parent mass error 2.0 Da, fragment mass error 0.8 Da. 
The filter criteria for high-confidence protein IDs included 1) above 98% probability; 2) minimal peptide ion 
score of 20; 3) at least two unique peptide sequences for each protein hit (to eliminate homologous 
proteins identified with the same set of peptides). The false positive rate of the aforementioned filter 
criteria was below 1.6%, estimated by using an individual reversed (decoy) sequence database of the 
entire mouse genome as described previously (16). In brief, the false positive rate was calculated by 
dividing the number of decoy hits by the number of hits acquired in search using the forward sequence 
database.  
Each protein ID with an IPI accession number was then assigned a major cellular function by 
using the online tool GO-Getter (http://bmf2.colorado.edu/go-getter/help.psp) based on Genome Ontology 
(GO) terms. Unassigned entries were searched against Swiss-Prot and NCBI for functional annotation. 
The number of transmembrane helices in each protein was predicted using TMHMM online program 
(http://www.cbs.dtu.dk/services/TMHMM/). 
Autophagy Induction by Starvation and Drug Treatment for Biochemical Study– Autophagy 
was induced by amino acid and serum starvation. J774 cells were washed three times with PBS and 
incubated in the starvation medium Earle’s balanced salts solution (EBSS, Invitrogen) for 2 h at 37 °C 
(17). Vinblastine (Sigma) was added to EBSS at 50 μM to accumulate autophagosomes by blocking their 
fusion with endosomes/lysosomes (18). Alternatively, protease inhibitors E64 (10 µM) and pepstatin A (2 
µM) were added to EBSS to prevent degradation of autophagosomal components in the mature 
autophagolysosomes. 3-Methyladenine (Sigma) was added to EBSS at 10 mM for autophagy inhibition 
(19). Cells were harvested after 2 h starvation in the presence or absence of a particular drug. We also 
performed subcellular fractionation from autophagy-induced J774 cells. Briefly, the cells were incubated 
with latex beads diluted in warm medium at a multiplicity of infection of 50:1 for 1 h. After washing the 
cells three times with PBS to remove free beads, we incubated them with EBSS in the presence or 
absence of a particular drug for another 2 h. Finally, the cells were lysed and phagosomes along with 
three additional subcelluar fractions were isolated in the same manner described earlier.    
             Autophagy Induction for Live Cell Imaging - We used a macrophage cell line stably 
expressing GFP-fused LC3 (kindly provided by Patrick Fitzgerald, St Jude’s Children's Research Hospital, 
Memphis, TN) to investigate LC3 trafficking during autophagy regulation. Cells were seeded on 8-well 
Nunc Lab-Tek Chambered Coverglass microscopy slides (Fisher) 20 h before imaging experiment. After 
incubation with latex beads (3.0 µm microspheres, Polysciences) for 1 h and extensive washes, the cells 
were treated with chloroquine (50 µM) or 3-MA (10 mM) for 2 h. During the final 15 min, LysoTracker Red 
DND-99 (Molecular Probes) was added at 100 nM. Cells were washed with PBS and treated with 15 
μg/mL Hoechst 33342 (Molecular Probes) in PBS for 2 min. Finally, the live cells were rinsed and imaged 
using a Zeiss 200M epifluorescence microscope. All images were deconvolved using the nearest 
neighbor deconvolution algorithm in the instrument software Slidebook 4.2 (Intelligent Imaging 
Innovations).  
Immunoblots – The total lysate from starved and drug-treated cells was obtained by sonicating 
cells in 2% SDS, 50mM Tris-HCl buffer (pH 8.0) with protease inhibitor cocktail (Calbiochem). After 
centrifugation, the supernatant was collected and the protein was quantified by the BCA assay. Protein 
extracts were separated by SDS-PAGE (4-12% for most experiments, except using 12% gel for LC3 
detection) and analyzed by Western blots with relevant antibodies. 3 ug of each subcellular fraction was 
loaded for detection of VAMP4, LC3 and JAK1, while 7 ug was loaded for TLR7 and TLR9 detection. All 
the total cell lysates were loaded at 15 ug. Phagosomal proteins from starved and drug-treated cells were 
extracted in the same manner as those from normal cells. Silver stain or protein controls were used to 
confirm equal protein loading.  
 
Results and discussion 
Phagosome Isolation and Membrane Fractionation 
 Fig. 1 illustrates our procedure for integrating subcellular fractionation techniques with the 
proteomic platform. We applied the method of Desjardins and coworkers for phagosome isolation (14). 
Briefly, latex beads were internalized into macrophages and the latex bead-containing (LBC) 
phagosomes were isolated by flotation on a sucrose gradient. Phagosomes isolated in this manner have 
been shown to be devoid of major contaminants (14, 20) and retain critical functional capabilities such as 
sequential fusion with endocytic vesicles (21) and microbicidal activity (22). Using radiolabeling and 
proteomic analysis, Desjardins and coworkers have previously estimated the potential contamination of 
LBC phagosomes to be below 5% (8). The first proteomic study of LBC phagosomes using this method 
identified about 140 proteins.  Not surprisingly, many of the observed proteins were highly abundant 
lysosomal hydrolases from the lumen of the vesicle.  
 In order to favor the recovery of integral or peripheral membrane proteins, which are at relatively 
low abundance, we lysed the phagosome pellet in sodium carbonate to release luminal proteins. The 
most loosely-bound membrane-associated components were then depleted by a second centrifugation.  It 
should be noted that several soluble proteins known to be transiently associated with phagosome 
membranes participate in vesicle traffic and signaling (such as the Rab family) (23-25). In an effort to 
retain some of these functionally significant proteins, we refrained from extensive subsequent washing of 
the membrane fraction. The resulting insoluble pellet was resuspended in concentrated detergent (4% 
SDS) to solubilize the residual proteins before separation by SDS-PAGE and identification by LC-MS/MS. 
Enrichment of unique proteins in the purified phagosomal membrane fraction compared to other fractions 
was confirmed by SDS-PAGE (Fig. S1). 
 In order to verify the purity of isolated phagosomes and their membrane fractions, we probed for 
the presence of known cellular organelle markers. GM-130 (Golgi-resident), Calnexin (ER-resident) and 
HSP-60 (mitochondria-resident) were detected only in non-phagosome fractions whereas the lysosomal-
associated membrane protein-1 (LAMP1) was clearly present in the phagosome fraction, as expected 
from the process of phagosome-lysosome fusion (Fig. 2A). In the absence of latex beads, LAMP1 was 
not observed in the corresponding fraction obtained by centrifugation, thus confirming its association with 
phagosomal membranes. 
 We next evaluated the composition of the phagosomal membrane preparation with respect to 
membrane-associated versus soluble proteins. Western blot analysis demonstrated that three known 
membrane markers of endosomal compartments, early endosomal associated protein (EEA1), LAMP1 
and transferrin receptor (TfR), were more abundantly represented in the membrane extract than in the 
soluble luminal fraction (Fig. 2B). All three endosomal markers were also observed in other subcellular 
fractions that include endogenous endocytic vesicles. In contrast to membrane markers, a significant 
portion of the soluble phagosomal protease cathepsin D (CatD) was released into the lumen fraction. 
However, this luminal protein was also observed as a contaminant in our membrane fraction. Thus, 
although our method enriches membrane-bound proteins considerably, the membrane fraction is not free 
of soluble contaminants.  
 
 Identification of Phagosomal Membrane-bound Proteins and Functional Categorization 
 Two types of mass spectrometers (Q-TOF and linear ion trap) were utilized to identify 
phagosomal membrane-bound proteins prepared in biological duplicates. The raw MS/MS data acquired 
from the two instruments were searched by a single engine (Mascot) and a stringent set of filter criteria 
were applied to select high-confidence protein IDs (see Methods for filter definition). A total of 546 non-
redundant IDs were generated after removing duplicate hits from the two datasets acquired using the 
different instruments. The details of protein identifications are listed in Table S1.  Interestingly, when we 
compared our dataset with that from the recent study conducted by Foster et al. (6), which identified 505 
proteins from entire phagosomes of a different mouse macrophage cell line (without membrane 
fractionation), 318 IDs were exclusively found in our dataset and 277 IDs were unique hits revealed by 
Foster’s experiment (Fig. 3A). All of the 546 proteins identified in our analysis were categorized into 14 
major classes according to specific cellular processes or functions annotated in public databases (Fig. 4 
and Table S3). We also listed these proteins in order of relative abundance as indicated by their ID score 
and number of identified peptides (Table S4). 
 Table S2 highlights unique proteins identified in the previously reported phagosomal proteome 
dataset as well as the one we acquired here, with a summary of their molecular weights (MW) and 
number of predicted transmembrane helices (TMHs) based on primary sequences. These data are 
presented graphically in Figs. 3B and C, respectively. The histogram of MWs shows an overall similar 
distribution profile, though our dataset contains slightly more IDs above 40 kD than the previously 
reported phagosomal proteomic dataset (6). We found 198 hits with more than one predicted TMH, which 
constitutes 36% of the entire phagosomal proteome in our analysis. By comparison, 27% of the 
phagosomal proteome reported by Foster was predicted to comprise transmembrane proteins (6), and a 
proteomic profile of Drosophila phagosomes estimated that value at 19.8% (8). Furthermore, proteins with 
more than one TMH were represented at higher frequency in our unique dataset compared to unique 
proteins in the previously reported datasets. Among our uniquely-identified proteins are ion channel and 
solute carrier proteins, a class of predicted transmembrane proteins with unknown function, as well as 
members of the vesicle-associated membrane protein (VAMP) family (Table S2). Overall, comparison of 
the identity and physical properties of proteins from the two datasets indicates that: (1) membrane 
enrichment allows for discovery of more transmembrane proteins without significantly altering MW 
distribution, and (2) two separate experiments with different cell lines using different mass spectrometers 
generated many unique IDs.  
 
Validation of Newly Identified Phagosomal Components 
 We selected several proteins for further validation by immunoblotting. Some were previously 
revealed in the earlier study by Desjardin (5), thus providing a measure of further validation, while others 
were newly identified in this study. As shown in Fig. 5, VAMP4, toll-like receptor (TLR)7 and TLR9, Janus 
kinase 1 (JAK1), and microtubule-associated protein 1 light chain 3 (LC3) were enriched in the 
phagosomal membrane fraction compared to other subcellular fractions or total cell lysate. Foster et al. 
also identified VAMP4 in macrophage phagosomes by mass spectrometry (6), and certain TLRs were 
similarly identified by Desjardin in a recent study of macrophage activation by cytokines (7).  By contrast, 
JAK1 and LC3, which participate in immune signaling and autophagy, respectively, had not been 
identified previously in phagosomes. The functional implications of each of these findings are summarized 
below. 
 VAMP4 is a member of the soluble N-ethylmaleimide-sensitive factor attachment receptor 
(SNARE) protein family that mediates intracellular membrane trafficking and fusion (26). VAMP4 is 
associated with the trans-Golgi network (TGN) and immature secretory granules (27) and is known to 
mediate trafficking of the sorting and recycling endosomes (28).  The protein has not been directly 
implicated in phagocytosis, but enrichment of VAMP4 on LBC phagosomes suggests a potential role in 
this pathway. In addition to VAMP4, many other proteins annotated with relevance to “Vesicle and protein 
trafficking” (Table S3), such as VAMP3, t-SNARE-interacting proteins and Sec family members, were 
newly identified in our study. Their potential contribution to the biogenesis or functions of macrophage 
phagosomes is an interesting future avenue of investigation. 
 The TLR family plays a critical role in innate immunity by recognizing a diverse range of microbial 
components (29). Several TLR members were identified in our study, as summarized in Table 1. TLR3, 7 
and 9 are intracellular receptors that sense bacterial or viral nucleic acids in endosomal compartments, 
but their relation to phagocytosis is not well understood. Using proteomic techniques, Desjardin found 
these three TLRs to be upregulated within macrophage phagosomes upon IFN-γ treatment (7). 
Surprisingly, an uncharacterized TLR member, TLR13, was identified in our study and its relative 
abundance (estimated by normalizing the number of identified peptides with the theoretical protein size 
(30)) was significantly higher than all of the other TLRs found in phagosomes (Table 1).  This observation 
suggests that further exploration of the role of TRL13 in phagocytosis is warranted. 
 JAK1, a protein tyrosine kinase, is known to associate with the cytoplasmic tail of cytokine 
receptors and plays a crucial role in initiating JAK/STAT signaling for enhancing microbial killing, antigen 
presentation, and inflammatory cytokine production (31). Fluorescence microscopy analysis a JAK1-YFP 
fusion showed the protein to be localized primarily at the plasma membrane (32). However, we identified 
native JAK1 in the phagosomal membranes of macrophage cells, suggesting a possible role in immune 
defense or other functions of this organelle. 
 Finally, LC3 piqued our interest because it is a widely used marker and essential component of 
the autophagy machinery. Upon the induction of autophagy, the 18-kD cytosolic precursor LC3-I is 
cleaved at its C-terminus and conjugated to phosphotidylethanolamine, generating a 16-kD form termed 
LC3-II (33). Lipid-modified LC3-II integrates into the membrane of autophagosomes and undergoes either 
recycling or degradation when autophagosomes fuse with late endosomes (13). Interestingly, we 
observed the specific enrichment of LC3-II on LBC phagosomal membranes, while both forms of LC3 
were observed in the total cell lysate (Fig. 5). It is unlikely that LC3-II found in LBC phagosomes came 
from contamination of the preparation with autophagosomal membranes. LBC phagosomes are known to 
be devoid of double-membrane vacuoles (a key feature of autophagosomes) and other major cellular 
compartments (5, 8, 14, 20).  The finding of LC3-II in LBC macrophages prompted us to explore the link 
between phagosomal components and autophagy more closely. 
 
Regulation of Phagosomal Components upon Autophagy Induction  
 Autophagy is a fundamental homeostatic process that enables cells to clean up or turn over 
portions of their own cytoplasm, mainly to obtain nutrients or to remove damaged organelles or toxic 
macromolecules (34). Autophagy functions are broadly associated with the control of cell development, 
suppression of tumorogenesis, prevention of neurodegeneration, and the immune response (11-13). 
Upon the initiation of autophagy, discrete portions of the cytoplasm are sequestered into a membrane-
enclosed vacuole termed the autophagosome. The cytosolic components or organelles trapped within a 
nascent autophagosome are eventually degraded after its fusion with late endosomes (13).   
 To assess the relationship of phagosomal LC3-II and autophagic activity, we induced autophagy 
by nutrient starvation (35) in the presence and absence of pharmacological modulators and monitored 
LC3-II levels within LBC phagosomes by Western blot analysis. Vinblastine was used to accumulate 
autophagosmes by preventing their fusion with endosomal compartments, and protease inhibitors were 
employed to accumulate autophagosomal components by preventing their degradation within 
autolysosomes (17). Further, we employed 3-methyladenine (3-MA), which blocks class III PI3Ks, as an 
inhibitor of the autophagy pathway (19, 36). The effectiveness of our phagosome purification from these 
autophagy-regulated cells was verified by the observation of similar patterns of organelle marker 
distribution in subcelluar fractions between control and drug-treated cells (SI Fig. S2).  
 As expected, LC3-II from total cell lysates of starved macrophages was more abundant in the 
presence of vinblastine or protease inhibitors than in their absence (Fig. 6A), consistent with the 
accumulation of autophagsomes. We also found LC3-II levels in LBC phagosomes to be elevated in the 
presence of vinblastine and protease inhibitors. Since LC3-II is predominantly associated with 
autophagosomes in non-phagocytic cells, and vinblastine blocks fusion of autophagosomes with 
endocytic compartments (33, 37), we suspect that LC3-II was directly transferred from autophagosomes 
to LBC phagosomes.  Consistent with this hypothesis, 3-MA treatment, which inhibited autophagosome 
formation, reduced LC3-II levels within LBC phagosomes (Fig. 6A). 
             Fluorescence microscopy of RAW cells stably expressing GFP-LC3 was employed to confirm the 
enrichment of LC3 on phagosome membranes during autophagy induction. We observed a distinct 
translocation of GFP-LC3 to the outermost ring of latex beads engulfed by macrophages treated with 
chloroquine-containing medium or starvation buffer (Fig. 7). These LC3-enriched phagosomes underwent 
successful fusion with lysosomes to become acidic vacuoles as indicated by LysoTracker stain (Fig. 7). In 
contrast, 3-MA treatment abolished both GFP-LC3 recruitment to phagosmes and LysoTracker staining 
due to inhibition of PI3K, an essential factor for autophagy induction as well as H+-ATPase complex 
assembly (38). Notably, we also observed diffuse LC3 staining around a portion of LBC phagosomes in 
control cells (Fig. 7), suggesting a low level of endogenous autophagic activity. This observation was 
consistent with our previous identification of LC3 in phagosome membranes from unstimulated 
macrophages using the proteomic approach. 
Similarly to LC3-II’s response to autophagy activity, the amount of VAMP4 in LBC phagosomes 
increased drastically when autophagosomes were accumulated, and decreased during inhibition of 
autophagy (Fig. 6A, lane 6-10). This trend suggests trafficking of VAMP4 between the two types of 
phagocytic compartments. We attributed the change of VAMP4 levels in phagosomes to intracellular 
translocation because the total cellular level of this protein was observed to be constant (Fig. 6A, lane 1-
5). The specific role of VAMP4 in either phagocytosis or autophagy has not been elucidated and would be 
an intriguing subject to pursue. JAK1, another newly identified phagosomal component, did not show a 
dramatic change of total expression or subcellular distribution upon autophagy induction (Fig. 6A).  
 We further probed the response of other identified phagosomal components – the endosomal 
markers EEA1, transferrin receptor (TrR), LAMP1 and the lysosomal hydrolase cathepsin D (CatD), to 
autophagy induction.  None of these proteins were found upregulated in phagosomes upon autophagy 
activation, nor were their overall cellular expression levels significantly altered (Fig. 6B). This result 
suggests that LC3-II and VAMP4 are specifically regulated in response to autophagy. We also noticed 
that the relative levels of the endosomal and lysosomal markers within phagosomes differed from one 
another, particularly upon treatment of macrophages with vinblastine (lane 9 in Fig. 6B). EEA1 was 
mostly retained in phagosomes whereas TfR was nearly depleted during autophagosome accumulation 
induced by the drug. In contrast, CatD and LAMP1 were slightly downregulated under the same treatment. 
The differential effects of vinblastine on recruitment of the various endosomal and lysosomal proteins to 
phagosomes might reflect distinct trafficking routes of the proteins between autophagosomes and LBC 
phagosomes.  
  
Conclusions 
 Proteomic analysis of a purified membrane fraction from LBC phagosomes resulted in the 
identification of many new proteins as well as clues regarding a relationship between phagocytosis and 
autophagy.  The two types of phagocytic compartments involved in these processes, generated by 
seemingly different pathways, may undergo a direct fusion that allows them to exchange and degrade 
constituents. The molecular machinery underlying the putative fusion event would be of significant future 
interest.  Autophagy is thought to facilitate the control and depletion of intracellular pathogens (39, 40).  In 
this regard the process has a functional relationship with phagocytosis, whereby microbes from the 
external environment are internalized and digested. A potential synergy between autophagocytosis and 
conventional phagocytosis of pathogenic microbes warrants further investigation. 
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Figure Legends 
Figure 1. Macrophage subcellular fractionation of phagosomal membranes and proteomic analyses. The 
blue band on top of the sucrose gradient is the LBC phagosome, and fractions 1, 2, 3 represent 
subcellular fractions below the phagosome band. 
Figure 2. Immunoblot analysis of subcellular fractions. (A) Blot probed for certain organelle markers. (B) 
Blot probed for membrane-bound endosomal markers and a lysosomal hydrolase. Fractions are denoted 
in Fig. 1. “No beads” indicates a sample taken from the same position occupied by LBC phagosomes in 
the sucrose gradient, yet derived from macrophages without beads. Each lane was loaded with 3 µg of 
total protein and equal loading was verified by silver stain (see SI Fig. S1). 
Figure 3. Comparison of this membrane-enriched phagosome proteomic data to the reported total 
phagosome proteomic data. (A) Venn diagram of total protein IDs from this membrane proteomic dataset 
and Foster’s comprehensive proteomic dataset6 for LBC phagosomes. (B) Histogram of predicted 
molecular weights of the proteins in the two datasets. (C) Histogram of the number of predicted 
transmembrane helices (TMH) in the unique proteins identified in the two datasets. Unique IDs refers to 
proteins exclusively reported in one dataset. 
Figure 4. Functional categorization of the 546 proteins identified in the phagosomal membrane fraction. 
“Others” combines four small groups: cell adhesion, nucleotide metabolism, protein folding and apoptosis. 
The detailed classification of each protein is shown in SI Table S3. 
Figure 5. Immunoblots of newly found proteins in phagosomal membranes. A portion of each subcellular 
fraction was separated by SDS-PAGE and analyzed by Western blot probing for VAMP4, LC3, JAK1, 
TLR7 and TLR9. TCL+ = total cell lysate obtained from RAW cells expressing HA-tagged TLR9; TCL- = 
total cell lysate from normal RAW cells. Anti-HA was used to probe for TLR9 expression.  
Figure 6. Regulation of phagosomal proteins in response to autophagy induction. Immunoblots of (A) 
newly found phagosomal components and (B) endosomal markers in either macrophage total cell lysate 
(TCL) (left) or phagosomal extracts (right). Macrophages were subjected to treatment with rich medium 
(lane 1 and 6), starvation (lane 2 and 7), starvation and 10 mM 3-methyladenine (3-MA) (lane 3 and 8), 
starvation and 50 μM vinblastine (VIN) (lane 4 and 9), starvation and protease inhibitors (INH) (lane 5 and 
10). The loading control was tubulin for macrophage TCL and actin for phagosome extracts. 
Figure 7. Translocation of GFP-LC3 to LBC phagosomes during autophagy induction. RAW cells stably 
expressing GFP-LC3 were allowed to internalize latex beads (3 µm) for 1 h, and then incubated with 
medium containing lysosomal protease inhibitor chloroquine (50 µM), EBSS buffer alone, EBSS 
containing 3-MA (10 mM) for 2 h. Control was treated with rich medium after bead internalization. 
LysoTracker was added in the last 15 min to stain acidic vacuoles. All cells were treated while alive with 
nuclear stain Hoechst 33342 (blue). Shown are representative images of different samples.  Scale bar = 5 
µm. 
 
Supporting Information 
Fig. S1. SDS-PAGE analysis of proteins extracted from subcellular fractions collected as shown in Fig. 1. 
Each lane was loaded with 3 µg of total protein.  
Fig. S2. . Immunoblot analysis of organelle markers in subcellular fractions isolated from macrophages 
subjected to (A) starvation buffer (EBSS); (B) starvation buffer with 3-MA (C) starvation buffer with 
vinblastine. Fractions are denoted in Fig. 1 and Fig. 2. See Experimental Procedures for details for drug 
treatment. Each lane was loaded with 3 µg of total protein.  
Table S1. Mascot results listing proteins identified in phagosomal membrane proteome. 
Table S2. Predicted molecular weights and numbers of helical domains of proteins from two datasets. 
The unique IDs from each dataset are highlighted.  
Table S3. Functional grouping of each protein identified in this phagosomal membrane proteomic study. 
Table S4. Relative abundance of phagosomal membrane proteins indicated by Mascot results 
Table 1.  Identification of TLR family members in the membrane proteome of LBC phagosomes 
Protein 
Name 
IPI 
accession 
no. 
Major ligands in 
innate immunity 
Predicted 
protein 
MW 
Mascot 
Score of 
Protein ID 
No. of 
peptide 
IDs 
Relative 
abundance 
index* 
TLR 2 IPI00131898 
Lipids and glycans 
from bacteria and 
fungi 
91 KD 152 6 3.6 
TLR 3 IPI00320618 dsRNA from viruses 104 KD 108 4 3.8 
TLR 7 IPI00122181 ssRNA from viruses 123 KD 897 47 38 
TLR 9 IPI00318748 DNA from viruses and bacteria 118 KD 146 10 8.5 
TLR 13 IPI00342691 Unknown 115 KD 1160 52 45 
* Calculated by dividing “No. of peptide IDs” with “Predicted protein MW”, then multiplying by 100.  
 
Lysis
Centrifugation
at 500 × g
Sucrose 
gradient 
fractionation
LBC phagosomes
Fraction 1
Disrupt phagosomes;  
pellet  membranes 
Collect and wash 
phagosomes
Protein extraction 
& separation by 
SDS‐PAGE
In‐gel digestion Analyze digests by 1D‐LC 
MS/MS using Q‐TOF or LTQ
Fraction 2
Fraction 3
Phagosome
membrane
Phagosome
lumen
P
M
N
= phagosomes
= mitochondria and other 
membrane‐enclosed organelles
= nucleus
Fig. 1
Fig. 2A 
GM‐130 
Calnexin
Hsp‐60 
LAMP1 
F
r
a
c
t
i
o
n
 
1
 
F
r
a
c
t
i
o
n
 
2
 
F
r
a
c
t
i
o
n
 
3
 
N
o
 
b
e
a
d
s
P
h
a
g
o
s
o
m
e
m
e
m
b
r
a
n
e
L
B
C
 
p
h
a
g
o
s
o
m
e
 
 
 
Fig. 2B
020
40
60
80
100
120
140
<
1
0
1
0
‐
2
0
2
0
‐
3
0
3
0
‐
4
0
4
0
‐
5
0
5
0
‐
6
0
 
6
0
‐
7
0
 
7
0
‐
8
0
 
8
0
‐
9
0
 
9
0
‐
1
0
0
 
1
0
0
‐
1
1
0
 
1
1
0
‐
1
2
0
1
2
0
‐
1
3
0
1
3
0
‐
1
4
0
1
4
0
‐
1
5
0
1
5
0
‐
2
0
0
>
2
0
0
N
u
m
b
e
r
 
o
f
 
P
r
o
t
e
i
n
 
I
D
s
Molecular Weight (KD)
Number of IDs of Phagosome 
Proteome by Foster et al.
Number of IDs of Our Phagosome 
Proteome
0
10
20
30
40
50
60
1 2 3 4 5 6 7 8 9 10 11 ≥12
N
u
m
b
e
r
 
o
f
 
U
n
i
q
u
e
 
P
r
o
t
e
i
n
 
I
D
s
Number of transmembrane helices
Number of Phagosomal 
Membrane Proteins by Foster 
et al.
Number of Our Phagosomal 
Membrane Proteins
umber  f IDs  f phagosome
proteome by Foster et al.
umber  f IDs of m mbrane‐
enriched phagosome proteome
umber of unique IDs of phagosome
proteome by Foster et al.
umber of unique IDs of membrane‐
enriched phagosome proteome
(B) (C)
318 228 277
Number of IDs of phagosome proteome 
by Foster et al.
Number of IDs of membrane-enriched 
phagosome proteome
(A)Fig. 3
 
Vesicle and protein 
trafficking (10%)
Membrane 
receptor/signalling
(9%)
Metabolism (10%)
Membrane structure 
and lipid rafts (4%)
Molecular transport 
(12%)
Immunity 
(5%)
Hydrolases
(6%)
Cell mobility/ 
cytoskeleton 
(12%)
GTPases (9%)
Biosynthesis 
(5%)
Others (7%)
Unknown (10%)
Fig. 4
Fig. 5
18 kD
VAMP4
JAK1
LC3‐II
TLR7
F
r
a
c
t
i
o
n
 
1
 
 
 
TLR9‐HA  
F
r
a
c
t
i
o
n
 
2
 
 
 
F
r
a
c
t
i
o
n
 
3
 
 
 
N
o
 
b
e
a
d
s
 
 
 
P
h
a
g
o
s
o
m
e
l
u
m
e
n
 
 
P
h
a
g
o
s
o
m
e
m
e
m
b
r
a
n
e
 
 
P
h
a
g
o
s
o
m
e
m
e
m
b
r
a
n
e
 
 
T
C
L
 
 
T
C
L
‐
T
C
L
+
 
 
16 kD
Fig. 6A
1 2 3 4 5
Phagosome extractsMacrophage TCL
JAK1
VAMP4
6      7      8      9    10
Loading 
control*
C
o
n
t
r
o
l
S
t
a
r
v
a
t
i
o
n
S
t
a
r
v
a
t
i
o
n
 
+
 
3
M
A
S
t
a
r
v
a
t
i
o
n
 
+
 
V
I
N
S
t
a
r
v
a
t
i
o
n
 
+
 
I
N
H
C
o
n
t
r
o
l
S
t
a
r
v
a
t
i
o
n
S
t
a
r
v
a
t
i
o
n
 
+
 
3
M
A
S
t
a
r
v
a
t
i
o
n
 
+
 
V
I
N
S
t
a
r
v
a
t
i
o
n
 
+
 
I
N
H
LC3‐I
LC3‐II
Fig. 6B
EEA1
pCatD
mCatD
LAMP1
TrR
Loading 
control*
Macrophage TCL Phagosome extracts
C
o
n
t
r
o
l
S
t
a
r
v
a
t
i
o
n
S
t
a
r
v
a
t
i
o
n
 
+
 
3
M
A
S
t
a
r
v
a
t
i
o
n
 
+
 
V
I
N
S
t
a
r
v
a
t
i
o
n
 
+
 
I
N
H
C
o
n
t
r
o
l
S
t
a
r
v
a
t
i
o
n
S
t
a
r
v
a
t
i
o
n
 
+
 
3
M
A
S
t
a
r
v
a
t
i
o
n
 
+
 
V
I
N
S
t
a
r
v
a
t
i
o
n
 
+
 
I
N
H
1       2      3       4       5 6      7      8      9     10
GFP-LC3DIC LysoTracker
Chloroquine
EBSS
EBSS 
+ 3-MA
Control
Fig. 7
 
SI Fig. S1
T
o
t
a
l
 
p
h
a
g
o
s
o
m
e
188KD—
98KD—
62KD—
49KD—
38KD—
28KD—
17KD—
6KD—
F
r
a
c
t
i
o
n
 
1
F
r
a
c
t
i
o
n
 
2
F
r
a
c
t
i
o
n
 
3
N
o
 
m
i
c
r
o
b
e
a
d
s
P
h
a
g
o
s
o
m
a
l
l
u
m
e
n
P
h
a
g
o
s
o
m
a
l
m
e
m
b
r
a
n
e
(A) (B) (C)
SI Fig. S2
